Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Sarcoma 39Leiomyosarcoma 10Osteosarcoma 8Breast Neoplasms 5Small Cell Lung Carcinoma 4Pancreatic Neoplasms 4Ovarian Neoplasms 4Neuroectodermal Tumors, Primitive, Peripheral 4Neoplasm Metastasis 4Melanoma 4Liposarcoma 4Histiocytoma, Malignant Fibrous 4Chondrosarcoma 4Carcinoma, Non-Small-Cell Lung 4Stomach Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Sarcoma, Synovial 3Salivary Gland Neoplasms 3Prostatic Neoplasms 3Hemangiosarcoma 3Esophageal Neoplasms 3Dermatofibrosarcoma 3Colorectal Neoplasms 3Bone Neoplasms 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Sarcoma, Kaposi 2Rhabdomyosarcoma 2Recurrent Uterine Corpus Sarcoma 2Neuroblastoma 2

Interventions

Docetaxel 2pazopanib 1lentiviral minigene vaccine of COVID-19 coronavirus 1Gemcitabine 1Bevacizumab 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Histiocytoma × Docetaxel × Sarcoma × Clear all
NCT01418001 2018-01-11

Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)

Memorial Sloan Kettering Cancer Center

Phase 1/2 Terminated
5 enrolled 6 charts
Sarcoma

Leiomyosarcoma, Sarcoma, Neurofibrosarcoma, Histiocytoma, Histiocytoma, Malignant Fibrous

NCT00887809 2016-01-25

Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
47 enrolled 7 charts
Sarcoma

Hemangiosarcoma, Leiomyosarcoma, Sarcoma, Histiocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡